Home > Boards > US Listed > Biotechs > PDL BioPharma Inc. (PDLI)

In at $7.62 - I think this is

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
ImOnABoat Member Profile
Member Level 
Followed By 536
Posts 9,409
Boards Moderated 2
Alias Born 05/02/09
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/14/2019 1:21:55 PM
PDL BioPharma Reaffirms Commitment To Shareholder Value Creation PR Newswire (US) - 11/14/2019 8:56:00 AM
Engine Capital Releases Presentation To Board Of PDL BioPharma PR Newswire (US) - 11/14/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2019 4:16:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 4:11:56 PM
PDL BioPharma Reports 2019 Third Quarter Financial Results PR Newswire (US) - 11/6/2019 4:05:00 PM
PDL BioPharma to Announce Third Quarter 2019 Financial Results on November 6, 2019 PR Newswire (US) - 10/30/2019 9:00:00 AM
PDL BioPharma Responds to Letter from Engine Capital PR Newswire (US) - 10/24/2019 10:06:00 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 10/23/2019 8:57:33 AM
Engine Capital Issues Open Letter to Board of PDL BioPharma PR Newswire (US) - 10/23/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/21/2019 7:06:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:01:36 AM
PDL BioPharma to Participate in the 2019 Cantor Fitzgerald Global Healthcare Conference PR Newswire (US) - 9/26/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2019 5:09:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 6:01:39 AM
PDL BioPharma Announces Private Exchange of Approximately $86.1 Million of Convertible Notes Due 2024 PR Newswire (US) - 9/12/2019 10:20:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/12/2019 6:02:29 AM
PDL BioPharma Announces Favorable Decision in Wellstat Diagnostics Litigation PR Newswire (US) - 9/11/2019 10:44:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/29/2019 4:43:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/19/2019 4:34:14 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:32:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:24:02 PM
Evofem Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire (US) - 8/5/2019 4:10:00 PM
PDL BioPharma to Announce Second Quarter 2019 Financial Results on August 7, 2019 PR Newswire (US) - 7/31/2019 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/8/2019 5:03:37 PM
ImOnABoat Member Level  Thursday, 09/18/14 01:35:59 PM
Re: None
Post # of 206 
In at $7.62 - I think this is way oversold at this point. 90% institutional ownership and the CEO himself put in over $1M of his own cash into this over the last 12 months, and at much higher PPS, I mind you. No way PDLI is going to die just like that. A bounce back to mid-$8's is quite likely following the news of the new accountant appointment next week.


This post is my personal opinion. I do not provide investment advice.

i.t.m.d.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist